Key result
Multivariable risk assessment calculators are integral to managing pulmonary arterial hypertension, aiding in timely referral to expert centers and guiding therapy escalation.
Why the study?
Pulmonary arterial hypertension carries an unacceptably high morbidity and mortality rate despite modern therapies, making robust risk assessment integral to management and timely referral.
Risk calculation is integral to managing pulmonary arterial hypertension, aiding in timely referral to expert centers and potentially lung transplantation.
Pulmonary arterial hypertension (PAH) is a chronic debilitating disease that carries an unacceptably high morbidity and mortality rate despite improved survival with modern therapies. The combination of several modifiable and nonmodifiable variables yields a robust risk assessment across various available clinical calculators. The role of risk calculation is integral to managing PAH and aids in the timely referral to expert centers and potentially lung transplantation. Studies are ongoing to determine the role of risk calculators in the framework of clinical trials and to elucidate novel markers of high risk in PAH.
No takes yet. Share an insight, caveat, or question.
Murthy et al. (2021) conducted a review in Pulmonary arterial hypertension. Risk assessment calculators was evaluated. Multivariable risk assessment calculators are integral to managing pulmonary arterial hypertension, aiding in timely referral to expert centers and guiding therapy escalation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: